Guild executive director announces his retirement
Pharmacy Guild of Australia executive director David Quilty has announced he will retire after six years in the job.
The Guild’s national president, George Tambassis, said that Mr Quilty had recently informed him of his intention to resign after more than six years of loyal service.
Mr Quilty will step down in two weeks, the Guild announced in a media release today (22 Feb).
Mr Tambassis said Mr Quilty wanted to spend more time with his family, and believed the Guild needed someone in the role who could give full commitment to the upcoming Seventh Community Pharmacy Agreement negotiations.
“David told me that he wants to give first priority to his family and that with the upcoming negotiation of the Seventh Community Pharmacy Agreement, he does not believe he is in a position to provide the absolute level of commitment that is required to deliver the best possible outcome for the community pharmacy sector.”
“This is entirely understandable and the timing of David’s resignation will enable the Guild to have a new Executive Director in place for this crucial negotiation,” Mr Tambassis said.
“On behalf of the National Council, I wish to express my profound appreciation to David for his enormous contribution to the Guild since November 2012. He has been a vital part of the Guild’s foremost achievements over the last six years, including the negotiation of the Sixth Community Pharmacy Agreement, the negotiation of the Pharmacy Compact and locking the pharmacy location rules in legislation”.
“David has been an untiring advocate for community pharmacy, working well beyond the normal call of duty, as well as ensuring the Guild is professionally run and delivers maximum value to members.
“He has also been a trusted and reliable source of advice and support for me since I became the Guild’s National President in October 2013″.
“I know that everyone associated with the Guild will wish David well and thank him for a job well done,” Mr Tambassis said.
Mr Quilty said it has been an honour to be the Guild’s executive director and an “enormous privilege” to represent the interests of Australia’s community pharmacies which play such a vital role in our health system.
“I sincerely thank all the people that I have worked with at the Guild for their personal support over the last six-and-a-half years.
“I wish to recognise the National Councillors with whom I’ve worked closely during my time as Executive Director and who make an enormous contribution of their time to the Guild. In particular, I thank George Tambassis, with whom I’ve worked very closely with since October 2013, including co-signing the Sixth Community Pharmacy Agreement and Pharmacy Compact together.
“Most of all, I thank all the hard-working staff across the Guild, both at the National and the Branch level, who are passionate about what they do and work tirelessly because they believe in the Guild and community pharmacy. Last, but not least, I thank all the members who have made it a pleasure working for the Guild during my time as Executive Director.
“I am proud of the considerable achievements over the last six-plus years, but this is the right time to pass on the baton, enabling a smooth transition to a new executive leader,” he said.
The Pharmaceutical Society of Australia acknowledged the leadership of David Quilty as he stepped down from the role.
PSA National President Dr Chris Freeman said PSA had enjoyed a good working relationship with the Pharmacy Guild under David Quilty’s leadership.
“On behalf of the PSA Board, CEO and staff, I thank David for his leadership over the past six years,” Dr Freeman said.
“David has been a passionate and relentless advocate for community pharmacy and will be remembered for his role in negotiating the Sixth Community Pharmacy Agreement in 2015, and Pharmacy Compact in 2017. We wish David all the very best in his retirement.
“PSA looks forward to continuing to engage constructively with the incoming Executive Director on key issues of common interest to progress the roles, recognition and remuneration for pharmacists, so they can provide the best possible care to patients.”